CN Patent

CN109310656A — 尿毒症性瘙痒症的治疗

Assigned to Trevi Therapeutics Inc · Expires 2019-02-05 · 7y expired

What this patent protects

本发明涉及用止痒组合物治疗尿毒症性瘙痒症的方法，其中所述方法在患者中提供治疗效果。

USPTO Abstract

本发明涉及用止痒组合物治疗尿毒症性瘙痒症的方法，其中所述方法在患者中提供治疗效果。

Drugs covered by this patent

diclofenac-potassium (DICLOFENAC POTASSIUM)

Patent Metadata

Patent number: CN109310656A
Jurisdiction: CN
Classification: —
Expires: 2019-02-05
Drug substance claim: No
Drug product claim: No
Assignee: Trevi Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.